Delta like ligand4 ameliorates liver fibrogenesis through inhibiting chemokines

HL Weng(Heidelberg University), Steven Dooley(Heidelberg University), O Park(National Institutes of Health), Y Liu(Heidelberg University), Bedair Dewidar(Tanta University), Tingting Feng(Zhejiang Cancer Hospital), Zhenyu Shen(Jiangsu University of Science and Technology), HG Augustin(German Cancer Research Center), Jingyi Hu(Shenzhen University), Bin Gao(National Institute on Alcohol Abuse and Alcoholism), Y Li(Zhejiang University)
Zeitschrift für Gastroenterologie
January 16, 2015
10.1055/s-0034-1397044
Cited by 0

Related Papers

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
|Cells|2019|822
<scp>TGF</scp>‐β signalling and liver disease
|FEBS Journal|2016|611
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
|Gut|2020|500
Hepatocytes: a key cell type for innate immunity
|Cellular and Molecular Immunology|2015|449
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
|Hepatology|2012|438